Abstract
The use of an angiotensin II type-1 receptor blocker for scleroderma renal crisis is controversial. We describe a 46-year-old woman presenting with a seizure secondary to hypertensive encephalopathy as the initial manifestation of scleroderma renal crisis. She had complete resolution of end organ damage with use of an angiotensin II type-1 receptor blocker. There may be a role for angiotensin II type-1 receptor blockers in the setting of scleroderma renal crisis with central nervous system involvement.
Original language | English (US) |
---|---|
Pages (from-to) | 205-208 |
Number of pages | 4 |
Journal | Journal of Clinical Rheumatology |
Volume | 11 |
Issue number | 4 |
DOIs | |
State | Published - Aug 1 2005 |
Keywords
- ACE inhibitors
- Hypertensive encephalopathy
- Scleroderma